What to Watch. USFDA clean chit bodes well for Divi’s Labs

Drug maker Divi’s Laboratories on Wednesday said its unit at Choutuppal in Telangana has undergone successful inspection by the US Food and Drug Administration (USFDA) from May 14-16, without any observations. The unit is engaged in active pharmaceutical ingredients and intermediates for generics. Apart from this, Divi’s Laboratories has a facility in Visakhapatnam. Shares of Divi’s Labs may react positively at the bourses following the green signal from the USFDA.